Lin DW. Point-Counterpoint: Active Surveillance Should Still be Preferred Management for All (or Nearly All) Men with Low Risk Prostate Cancer. J Urol 2022 Dec 27:101097JU0000000000003134. doi: 10.1097/JU.0000000000003134.
PMID: 36573929